Compare WLKP & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WLKP | PSNL |
|---|---|---|
| Founded | 2014 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 798.3M | 729.1M |
| IPO Year | 2014 | 2019 |
| Metric | WLKP | PSNL |
|---|---|---|
| Price | $22.46 | $8.48 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $12.20 |
| AVG Volume (30 Days) | 28.3K | ★ 2.4M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | ★ 8.25% | N/A |
| EPS Growth | N/A | ★ 33.58 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,166,695,000.00 | $69,648,000.00 |
| Revenue This Year | $19.48 | $15.34 |
| Revenue Next Year | $5.24 | $41.46 |
| P/E Ratio | $15.30 | ★ N/A |
| Revenue Growth | ★ 2.71 | N/A |
| 52 Week Low | $17.75 | $3.84 |
| 52 Week High | $23.88 | $11.50 |
| Indicator | WLKP | PSNL |
|---|---|---|
| Relative Strength Index (RSI) | 44.91 | 72.09 |
| Support Level | $21.60 | $7.74 |
| Resistance Level | $22.62 | $9.64 |
| Average True Range (ATR) | 0.50 | 0.63 |
| MACD | -0.11 | 0.31 |
| Stochastic Oscillator | 25.27 | 93.27 |
Westlake Chemical Partners LP is a part of the chemical industry in the United States. Its operations are conducted through OpCo, it acquires and develops ethylene production facilities, which convert ethane into ethylene. OpCo sells ethylene and its co-products, such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen, to Westlake and other customers located in the United States. Its assets include three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.